Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Lipitor Switch Decision Could Portend Pfizer’s Consumer Product Future

This article was originally published in The Tan Sheet

Executive Summary

As CEO Ian Read leaves open a door for the firm to unload the consumer business, industry consultant Steve Francesco says Pfizer’s decision to end its Lipitor switch program could move the business out the door.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register